Neurotoxic disorders of organophosphorus compounds and their managements

Archives of Iranian Medicine

Volumn 11, Issue 1, 2008, Pages 65-89

  Balali Mood, Mahdi ^a   Balali Mood, Kia ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Anticholinesterase agents; Chemical warfare agents; Neurotoxic disorders; Organophosphate pesticides; Poisoning

Indexed keywords

1 (4 CARBAMOYLPYRIDINIO) 1' (2 HYDROXYIMINOMETHYLPYRIDINIO)DIMETHYL ETHER; 1 [2,4 BIS(HYDROXYIMINOMETHYL)PYRIDINIO] 1' (4 CARBAMOYLPYRIDINIO)DIMETHYL ETHER DIIODIDE; [(3 BENZOYL 1 PYRIDINIOMETHYL) (2 HYDROXYIMINOMETHYL 1 PYRIDINIOMETHYL)] ETHER; ACETYLCHOLINE; ACETYLCHOLINESTERASE; ATROPINE; BENACTYZINE; BICARBONATE; CHOLINERGIC RECEPTOR; CHOLINESTERASE; DIAZEPAM; GACYCLIDINE; MAGNESIUM SULFATE; MESYLIC ACID; OBIDOXIME; ORGANOPHOSPHORUS COMPOUND; OXIME; PESTICIDE; PHYSOSTIGMINE; PRALIDOXIME; PRALIDOXIME CHLORIDE; PRALIDOXIME MESILATE; PYRIDOSTIGMINE; TRIHEXYPHENIDYL; TRIMEDOXIME;

ABSORPTION; ADJUVANT THERAPY; ANTICHOLINERGIC SYNDROME; BIOTRANSFORMATION; CARBAMOYLATION; CENTRAL NERVOUS SYSTEM DISEASE; CHEMICAL STRUCTURE; CHEMICAL WARFARE; CLINICAL FEATURE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONVULSION; DEVELOPING COUNTRY; DISEASE COURSE; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG DOSE REGIMEN; DRUG EFFICACY; DYSPNEA; ENZYME ACTIVITY; ENZYME INHIBITION; EXCRETION; GAS CHROMATOGRAPHY; HEART ARREST; HEMOPERFUSION; HIGH RISK POPULATION; HUMAN; INTOXICATION; IRAN; JAPAN; LD 50; LIVER TOXICITY; LOADING DRUG DOSE; MASS SPECTROMETRY; METABOLIC ACIDOSIS; METABOLISM; MIOSIS; NEUROLOGICAL COMPLICATION; NEUROPATHY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PROGNOSIS; PROTECTIVE CLOTHING; QUANTITATIVE ANALYSIS; RECOMMENDED DRUG DOSE; REVIEW; RISK REDUCTION; SEIZURE; SENSITIVITY AND SPECIFICITY; UNSPECIFIED SIDE EFFECT;

ANTIDOTES; CHEMICAL WARFARE AGENTS; CHOLINESTERASE INHIBITORS; DECONTAMINATION; HUMANS; INSECTICIDES; NERVOUS SYSTEM DISEASES; NEUROTOXINS; ORGANOPHOSPHORUS COMPOUNDS; TRIAGE;

EID: 39049114605     PISSN: 10292977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (108)

1. Balali-Mood M, Shariat M. Treatment of organophosphate poisoning. Experience of nerve agents and acute pesticide poisoning on the effects of oximes. J Physiol Paris. 1998; 92: 375-378.
2. Ballantyne B, Marrs T. Overview of the biological and clinical aspects of organophosphates and carbamates. In: Ballantyne B, Marrs TC, eds. Clinical and Experimental Toxicology of Organophosphates and Carbamates. Oxford: Butterworth & Heinemann; 1992: 3-14.
3. Minton NA, Murray VS. A review of organophosphate poisoning. Med Toxicol Adverse Drug Exp. 1988; 3: 350-375.
4. Jeyaratnam J, Maroni M. Organophosphorous compounds. Toxicology. 1994; 91: 15-27.
5. Lockridge O, Masson P. Pesticides and susceptible populations: people with butyrylcholinestrase genetic variants may be at risk. Neurotoxicology. 2000; 21: 113-126.
6. Sidell FR. Soman and sarin: clinical manifestations and treatment of accidental poisoning by organophosphates. Clin Toxicol (Phila). 1974; 7: 1-17.
7. Holmsted B. The third symposium on the prophylaxis and treatment of chemical poisons. Fund Appl Toxicol. 1985; 5: S1-S9.
8. Eto M. Organophosphorous Pesticides: Organic and Biological Chemistry. Cleveland: CRC Press; 1974.
9. Kwong K. Organophosphate pesticides: biochemistry and clinical toxicology. Ther Drug Monit. 2002; 24: 144-149.
10. Lotti M. Low-level exposures to organophosphorous esters and peripheral nerve function. Muscle Nerve. 2002; 25: 492-504.
11. Forget G. Pesticides and the third world. J Toxicol Environ Health. 1991; 32: 11-31.
12. Eddleston M, Gunnell D, Karunaratne A, de Silva D, Sheriff MH, Buckley NA. Epidemiology of intentional self-poisoning in rural Sri Lanka. Br J Psychiatry. 2005; 187: 583-584.
13. Amr MM. Pesticide monitoring and its health problems in Egypt, a Third World country. Toxicol Lett. 1999; 107: 1-13.
14. Cocker J, Mason HJ, Garfitt SJ, Jones K. Biological monitoring of exposure to organophosphate pesticides. Toxicol Lett. 2002; 134: 97-103.
15. Brown MA, Brix KA. Review of health consequences from high-, intermediate-, and low-level exposure to organophosphorus nerve agents. J Appl Toxicol. 1998; 18: 393-408.
16. Eddleston M, Karalliedde L, Buckley N, Fernando R, Hutchinson G, Isbister G, et al. Pesticide poisoning in the developing world - a minimum pesticides list. Lancet. 2002; 360: 1163-1167.
17. Thiermann H, Szinicz L, Eyer F, Worek F, Eyer P, Felgenhauer N, et al. Modern strategies in therapy of organophosphate poisoning. Toxicol Lett. 1999; 107: 233-239.
18. Balali-Mood M, Balali-Mood K. Nerve agents. In: Brent J, ed. Critical Care Toxicology. Philadelphia, USA: Elsevier Mosby. 2005: 1379-1393.
19. Black R, Harrison J. The chemistry of organophosphorous chemical warfare agents. In: Hartley FR, ed. The Chemistry of Organophosphorus Compounds. Chichester: John Wiley and Sons; 1996: 781-840.
20. Black RM, Clarke RJ, Read RW, Reid MTJ. Application of gas chromatography-mass spectrometry and gas chromatography-tandem mass spectrometry to the analysis of chemical warfare samples, found to contain residues of the nerve agent sarin, sulfur mustard and their degradation products. J Chromatogr A. 1994; 662: 301-321.
21. Tokuda Y, Kikuchi M, Takahashi O, Stein G. Prehospital management of sarin nerve gas terrorism in urban settings: 10 years of progress after the Tokyo subway sarin attack. Resuscitation. 2006; 68: 193-202.
22. Nozaki H, Aikawa N, Fujishima S, Suzuki M, Shinozawa Y, Hori S, et al. A case of VX poisoning and the difference from sarin. Lancet. 1995; 346: 698-699.
23. Nagao M, Takatori T, Matsuda Y, Nakajima M, Iwase H, Iwadate K. Definitive evidence for the acute sarin poisoning diagnosis in the Tokyo subway. Toxicol Appl Pharmacol. 1997; 144: 198-203.
24. Worek F, Koller M, Thiermann H, Szinicz L. Diagnostic aspects of organophosphate poisoning. Toxicology. 2005; 214: 182-189.
25. Sidell FR, Borak J. Chemical warfare agents: II. Nerve agents. Ann Emerg Med. 1992; 21: 865-871.
26. Josse D, Lockridge O, Xie W, Bartels CF, Schopfer LM, Masson P. The active site of human paraoxonase (PON1). J Appl Toxicol. 2001; 21 (suppl 1): S7-S11.
27. Dunn M, Sidell F. Progress in medical defense against nerve agents. JAMA. 1998; 262: 649-652.
28. Ooms AJJ, van Dijk C. The reaction of organophosphorous compounds with hydrolytic enzymes - III: the inhibition of chymotrypsin and trypsin. Biochem Pharmacol. 1966; 15: 1361-1377.
29. Boter HL, Ooms AJJ. Stereospecificity of hydrolytic enzymes in their reaction with optically active organophosphorus compounds - II: the inhibition of aliesterase, acetylesterase, chymotrypsin, and trypsin by S-atkyl p-nitrophenyl methylphosphonothiolates. Biochem Pharmacol. 1967; 16: 1563-1569.
30. Black R, Harrison J, Read R. The interaction of sarin and soman with plasma proteins: the identification of a novel phosphonylation site. Arch Toxicol. 1999; 73: 123-126.
31. Sogorb MA, Vilanova E. Enzymes involved in the detoxification of organophosphorous, carbamate, and pyrethroid insecticides through hydrolysis. Toxicol Lett. 2002; 128: 215-228.
32. Eyer P, Worek F, Kiderlen D, Sinko G, Stuglin A, Simeon-Rudolf V, et al. Molar absorption coefficients for the reduced Ellman reagent: reassessment. Anal Biochem. 2003; 312: 224-227.
33. Morita H, Yanagisawa N, Nakajima T, Shimizu M, Hirabayashi H, Okudera H, et al. Sarin poisoning in Matsumoto, Japan. Lancet. 1995; 346: 290-293.
34. Lee M, Clement J. Effect of soman poisoning in haematology and coagulation parameters and serum biochemistry in rabbits. Milit Med. 1990; 155: 244-249.
35. Grob D. The manifestations and treatment of poisoning due to nerve gas and other organic phosphate anticholinesterase compounds. Arch Intern Med. 1956; 98: 221-239.
36. Ohbu S, Yamashina A, Takasu N. Sarin poisoning on Tokyo subway. Southern Med J. 1997; 90: 587-593.
37. Young G, Koplovitz I. Acute toxicity of cyclohexylmethylphosphonofluoridate (CMPF) in rhesus monkeys: serum biochemical and hematologic changes. Arch Toxicol. 1995; 69: 379-383.
38. Rickell D, Glenn J, Houston W. Medical defense against nerve agents: new direction. Milit Med. 1987; 152: 35-41.
39. Gordon J, Inns R, Johnson M. The delayed neuropathic effects of nerve agents and other organophosphate compounds. Arch Toxicol. 1983; 52: 82-86.
40. Albuquerque EX, Deshpande SS, Kawabuchi M, et al. Multiple actions of anticholinesterase agents on chemosensitive synapses: molecular basis for prophylaxis and treatment of organophosphate poisoning. Fundam Appl Toxicol. 1985; 5: S182-S203.
41. Ecobichon DJ, Comeau AM. Pseudocholinesterases of mammalian plasma: physicochemical properties and organophosphate inhibition in eleven species. Toxicol Appl Pharmacol. 1973; 24: 92-100.
42. Liu D, Watanabe H, Ho I. Acute effects of soman, sarin, and tabun on cyclic nucleotide metabolism in rat stratium. J Toxicol Environ Health. 1986; 19: 23-32.
43. van der Schans MJ, Lander BJ, Wiel Hvd, Langenberg JP, Benschop HP. Toxicokinetics of the nerve agent (±)-VX in anesthetized and atropinized hairless guinea pigs and marmosets after intravenous and percutaneous administration. Toxicol Appl Pharmacol. 2003; 191: 48-62.
44. van der Schans MJ, Polhuijs M, van Dijk C, Degenhardt CE, Pleijsier K, Langenberg JP, et al. Retrospective detection of exposure to nerve agents: analysis of phosphofluoridates originating from fluoride-induced reactivation of phosphylated BuChE. Arch Toxicol. 2004; 78: 508-524.
45. Minami M, Hui D, Katsumata M, Inagaki H, Boulet C. Method for the analysis of the methylphosphonic acid metabolites of sarin and its ethanol-substituted analogue in urine as applied to the victims of the Tokyo sarin disaster. J Chromatogr B Biomed Sci Appl. 1997; 695: 237-244.
46. Sivam S, Hoskins B, Ho I. An assessment of comparative acute toxicity of diisopropyl-fluorophosphate, Tabun, Sarin, and soman in relation to cholinergic and GABAergic enzyme activities in rats. Fundam Appl Toxicol. 1984; 19: 23-32.
47. Rowntree DW, Nevin S, Wilson A. The effects of diisopropylfluorophosphonate in schizophrenia and manic depressive psychosis. J Neurol Neurosurg Psychiatry. 1950; 13: 47-62.
48. Senanayake N, Karalliede L. Neurotoxic effects of organophosphorous insecticides. An intermediate syndrome. N Engl J Med. 1987; 316: 761-763.
49. Ludomirsky A, Klein HO, Sarelli P, Becker B, Hoffman S, Taitelman U, et al. Q-T prolongation and polymorphous ("torsade de pointes") ventricular arrhythmias associated with organophosphorus insecticide poisoning. Am J Cardiol. 1982; 49: 1654-1658.
50. Rengstorff RH. Accidental exposure to sarin: vision effects. Arch Toxicol. 1985; 56: 201-203.
51. Decandole C, Duglas W, Evans C. The failure of respiration in death by anticholinesterase poisoning. Br J Pharmacol. 1953; 8: 466-475.
52. Stewart W. The effects of sarin and atropine on the respiratory center and neuromuscular junctions of the rat. Can J Biochem Physiol. 1959; 37: 651-660.
53. Rickett D, Glenn J, Beers E. Central respiratory effects versus neuromuscular actions of nerve agents. Neurotoxicology. 1953; 8: 466-475.
54. Singer A, Jaax NK, Graham J. Cardiomyopathy in soman and sarin intoxicated rat. Toxicol Lett. 1987; 36: 243-249.
55. Furlong CE, Li WF, Richter RJ, Shih DM, Lusis AJ, Alleva E, et al. Genetic and temporal determinants of pesticide sensitivity: role of paraoxonase (PON1). Neurotoxicology. 2000; 21: 91-100.
56. Worek F, Kleine A, Falke K, Szinicz L. Arrhythmias in organophosphate poisoning: effect of atropine and bispyridinium oximes. Arch Int Pharmacodyn Ther. 1995; 329: 418-435.
57. De Bleecker J, van den Neucker K, Willems J. The intermediate syndrome in organophosphate poisoning: presentation of a case and review of the literature. J Toxicol Clin Toxicol. 1992; 30: 321-331.
58. Klette KL, Levine B, Dreka C, Smith ML, Goldberger BA. Cholinesterase activity in postmortem blood as a screening test for organophosphate/ chemical weapon exposure. J Forensic Sci. 1993; 38: 950-955.
59. McLeod C, Singer A, Harrington D. Acute neuropathology in soman poisoned rats. Neurotoxicology. 1984; 5: 53-58.
60. Cao CJ, Mioduszewski RJ, Menking DE, Valdes JJ, Katz EJ, Eldefrawi ME, et al. Cytotoxicity of organophosphate anticholinesterases. In Vitro Cell Dev Biol Anim. 1999; 35: 493-500.
61. Worek F, Koller M, Thiermann H, Szinicz L. Diagnostic aspects of organophosphate poisoning. Toxicology. 2005; 214: 182-189.
62. Schier J, Ravikumar P, Nelson L, Heller M, Howland M, Hoffman R. Preparing for chemical terrorism: stability of injectable atropine sulfate. Acad Emerg Med. 2004; 11: 329-334.
63. Anzueo A, Berdine G, Moore G. Pathophysiology of soman intoxication in primates. Toxicol Appl Pharmacol. 1986; 86: 56-68.
64. Sekijima Y, Morita H, Yanagisawa N. Follow-up of sarin poisoning in Matsumoto. Ann Intern Med. 1997; 127: 1042-1046.
65. Mulchandani A, Kaneva I, Chen W. Detoxification of arganophosphate nerve agents by immobilized Escherichia coli with surface-expressed organophosphorus hydrolase. Biotechnol Bioeng. 1999; 63: 216-223.
66. Mulchandani A, Pan S, Chen W. Fiber-optic enzyme biosensor for direct determination of organophosphate nerve agents. Biotechnol Prog. 1999; 15: 130-134.
67. Polhuijs M, Langenberg JP, Benschop HP. New method for retrospective detection of exposure to organophosphorus anticholinesterases: application to alleged sarin victims of Japanese terrorists. Toxicol Appl Pharmacol. 1997; 146: 156-161.
68. Nagao M, Takatori T, Matsuda Y. Definitive evidence for the acute sarin poisoning diagnosis in the Tokyo subway. Toxicol Appl pharmacol. 1997; 144: 198-203.
69. Ellman G, Courtney K, Anders V, Featherstone R. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961; 7: 88-95.
70. Worek F, Mast U, Kiderlen D, Diepold C, Eyer P. Improved determination of acetylcholinesterase activity in human whole blood. Clinica Chimica Acta. 1999; 288: 73-90.
71. Taylor P, Kovarik Z, Reiner E, Radic Z. Acetylcholinesterase: converting a vulnerable target to a template for antidotes and detection of inhibitor exposure. Toxicology. 2007; 233: 70-78.
72. Mortensen SR, Brimijoin S, Hooper MJ, Padilla S. Comparison of the in vitro sensitivity of rat acetylcholinesterase to chlorpyrifos-oxon: what do tissue IC50 values represent? Toxicol Appl Pharmacol. 1998; 148: 46-49.
73. Worek F, Widmann R, Knopff O, Szinicz L. Reactivating potency of obidoxime, pralidoxime, HI 6 and HLo 7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds. Arch Toxicol. 1998; 72: 237-243.
74. Noort D, Benschop HP, Black RM. Biomonitoring of exposure to chemical warfare agents: a review. Toxicol Appl Pharmacol. 2002; 184: 116-126.
75. Black RM, Read RW. Application of liquid chromatography-atmospheric pressure chemical ionisation mass spectrometry, and tandem mass spectrometry, to the analysis and identification of degradation products of chemical warfare agents. J Chromatogr A. 1997; 759: 79-92.
76. Katagi M, Nishikawa M, Tatsuno M, Tsuchihashi H. Determination of the main hydrolysis product of O-ethyl S-2-diisopropylaminoethyl methylphosphonothiolate, ethyl methylphosphonic acid, in human serum. J Chromatogr B Biomed Sci Appl. 1997; 689: 327-333.
77. Munro N. Toxicity of the organophosphate chemical warfare agents GA, GB, and VX: implications for public protection. Environ Health Perspect. 1994; 102: 18-37.
78. Wolfe AD, Rush RS, Doctor BP, Koplovitz I, Jones D. Acetylcholinesterase prophylaxis against organophosphate toxicity. Fundam Appl Toxicol. 1987; 9: 266-270.
79. Raveh L, Grunwald J, Marcus D, Papier Y, Cohen E, Ashani Y. Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity. In vitro and in vivo quantitative characterization. Biochem Pharmacol. 1993; 45: 2465-2474.
80. Caranto GR, Waibel KH, Asher JM, Larrison RW, Brecht KM, Schutz MB, et al. Amplification of the effectiveness of acetylcholinesterase for detoxification of organophosphorus compounds by bis-quaternary oximes. Biochem Pharmacol. 1994; 47: 347-357.
81. Saxena A, Maxwell DM, Quinn DM, Radic Z, Taylor P, Doctor BP. Mutant acetylcholinesterases as potential detoxification agents for organophosphate poisoning. Biochem Pharmacol. 1997; 54: 269-274.
82. Broomfield CA, Lockridge O, Millard CB. Protein engineering of a human enzyme that hydrolyzes V and G nerve agents: design, construction and characterization. Chem Biol Interact. 1999; 119-120: 413-418.
83. Cheng TC, DeFrank JJ, Rastogi VK. Alteromonas prolidase for organophosphorus G-agent decontamination. Chem Biol Interact. 1999; 119-120: 455-462.
84. Gordon RK, Feaster SR, Russell AJ, LeJeune KE, Maxwell DM, Lenz DE, et al. Organophosphate skin decontamination using immobilized enzymes. Chem Biol Interact. 1999; 119-120: 463-470.
85. Sawyer TW, Weiss MT, Boulet CA, Hansen AS. Toxicity of organophosphate nerve agents and related phosphonylated oximes compared to their anticholinesterase activity in neuron cultures. Fundam Appl Toxicol. 1991; 17: 208-214.
86. Balali-Mood M, Ayati MH, Ali-Akbarian H. Effect of high doses of sodium bicarbonate in acute organophosphorous pesticide poisoning. Clin Toxicol (Phila). 2005; 43: 571-574.
87. Tuovinen K, Hanninen O. Protection of mice against soman by pretreatment with eptastigmine and physostigmine. Toxicology. 1999; 139: 233-241.
88. Kassa J, Fusek J. The positive influence of a cholinergic-anticholinergic pretreatment and antidotal treatment on rats poisoned with supralethal doses of soman. Toxicology. 1998; 128: 1-7.
89. Munro NB, Watson AP, Ambrose KR, Griffin GD. Treating exposure to chemical warfare agents: implications for health care providers and community emergency planning. Environ Health Perspect. 1990; 89: 205-215.
90. Holstege CP, Kirk M, Sidell FR. Chemical warfare. Nerve agent poisoning. Crit Care Clin. 1997; 13: 923-942.
91. Orma P, Middleton R. Aerosolized atropine as an antidote to nerve gas. Ann Pharmacother. 1992; 26: 937-938.
92. van Helden HP, Busker RW, Melchers BP, Bruijnzeel PL. Pharmacological effects of oximes: how relevant are they? Arch Toxicol. 1996; 70: 779-786.
93. Nelson-Corvino T, Nahata M, Angelos M, Tschampel M, Morosco R. Availability, stability, and sterility of pralidoxime for mass casualty use. J Ann Emerg Med. 2006; 47: 272-277.
94. Dawson R. Review of oximes available for treatment of nerve agent poisoning. J Appl Toxicol. 1994; 14: 317-331.
95. Boskovic B, Kovacevic V, Jovanovic D. PAM-2 Cl, HI-6, and HGG-12 in soman and tabun poisoning. Fundam Appl Toxicol. 1984; 4: S106-S115.
96. Clement JG, Hansen AS, Boulet CA. Efficacy of HLo-7 and pyrimidoxime as antidotes of nerve agent poisoning in mice. Arch Toxicol. 1992; 66: 216-219.
97. Lundy PM, Hansen AS, Hand BT, Boulet CA. Comparison of several oximes against poisoning by soman, tabun, and GF. Toxicology. 1992; 72: 99-105.
98. Melchers BP, Philippens IH, Wolthuis OL. Efficacy of HI-6 and HLo-7 in preventing incapacitation following nerve agent poisoning. Pharmacol Biochem Behav. 1994; 49: 781-788.
99. Cassel G, Karlsson L, Waara L, Ang KW, Goransson-Nyberg A. Pharmacokinetics and effects of HI 6 in blood and brain of soman-intoxicated rats: a microdialysis study. Eur J Pharmacol. 1997; 332: 43-52.
100. Koplovitz I, Menton R, Matthews C, Shutz M, Nalls C, Kelly S. Dose-response effects of atropine and HI-6 treatment of organophosphorus poisoning in guinea pigs. Drug Chem Toxicol. 1995; 18: 119-136.
101. Marrs T. The role of diazepam in the treatment of nerve agent poisoning in a civilian population. Toxicol Rev. 2004; 23: 145-157.
102. Balali-Mood M, Salimifar H, Shariate M. Effects of sodium bicarbonate in human organophosphate poisoning. "Proceedings of the Third International Chemical and Biological Medical Treatment Symposium. Spiez, Switzerland; May 7-12, 2000: 18-27.
103. Balali-Mood M, Afshari R, Kahrom M, Ayati MH, Ali-Akbarian H, Zare G. Use of high doses of sodium bicarbonate in acute organophosphorous pesticide poisoning is advancing. Clin Toxicol (Phila). 2007; 45: 92-93.
104. Roberts DM, Dawson AH, Hittarage A, Jeganathan K, Sheriff MH, Buckley NA. Plasma alkalinization for acute organophosphorus poisoning - is it a reality in the developing world? Clin Toxicol (Phila). 2007; 45: 90-91.
105. Castro CA, Larsen T, Finger AV, Solana RP, McMaster SB. Behavioral efficacy of diazepam against nerve agent exposure in rhesus monkeys. Pharmacol Biochem Behav. 1992; 41: 159-164.
106. Balali-Mood M, Balali-Mood K, Hosseini-Shirazi F. Recent advances in treatment of acute organophosphorous nerve agents poisoning. Iran J Pharm Res. 2006; 2: 82-88.
107. Volans A. Sarin: guidelines on the management of victims of a nerve gas attack. J Accid Emerg Med. 1996; 13: 202-206.
108. Newmark J. Therapy for nerve agent poisoning. Arch Neurol. 2004; 61: 649-652.